August 9, 2019
JRC physician Dr. Robert Battat presented his findings at Digestive Disease Week 2019 demonstrating the efficacy of a serum-based biomarker assay in identifying mucosal inflammation with similar accuracy to fecal calprotectin in patients with Crohn’s disease
Category:
News and Announcements